Exploring the binding of Pt drugs to gold nanoparticles for controlled passive release of cisplatin

Related Experiment Video

Updated: Jun 2, 2026

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

Joan Comenge1, Francisco M Romero, Carmen Sotelo

  • 1Institut Català de Nanotecnologia, 08163 Campus UAB Bellaterra, Spain.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|May 3, 2011
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Related Experiment Videos

Last Updated: Jun 2, 2026

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Articles linked to this work by shared authors, journal, and citation graph.

Family Screening and Disease Predictors in Gene-Elusive Dilated Cardiomyopathy.

JACC. Heart failure·2026

Arrhythmias detected by implanted cardiac rhythm recorders in transthyretin cardiac amyloidosis.

Revista espanola de cardiologia (English ed.)·2026

Diesel exhaust particles induce a two-stage program of myocardial oxidative stress involving NADPH oxidases and mitochondrial dysfunction: Modulation by CeO2 nanoparticles.

Ecotoxicology and environmental safety·2026

Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.

JACC. Heart failure·2026

Guidelines for prevention and management of complications of injection drug use: A WikiGuidelines group consensus statement.

The American journal of medicine·2026

Integrating genetics and phenotyping in clinical management of dilated and non-dilated left ventricular cardiomyopathy.

European journal of heart failure·2026

Nanoarchitectonics via emulsion interfacial in situ polymerization for enhanced cross-presentation and antitumor immunity.

Journal of controlled release : official journal of the Controlled Release Society·2026

Tetrahedral DNA engineered Janus nanoplatform for potentiated Zn2+ interference therapy and cGAS-STING activation via efficient delivery of exogenous DNA.

Journal of controlled release : official journal of the Controlled Release Society·2026

Ritlecitinib lipid microsphere development and model-facilitated determination of regional gastrointestinal delivery in healthy volunteers.

Journal of controlled release : official journal of the Controlled Release Society·2026

Uncovering the lymphatic uptake, pharmacokinetics, and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection.

Journal of controlled release : official journal of the Controlled Release Society·2026

Needle-free jet injection in translation: a narrative review of the state of the art, key trends, and research gaps.

Journal of controlled release : official journal of the Controlled Release Society·2026

Redox-responsive nanoparticles prevent post-ablation hepatocellular carcinoma recurrence by dual regulation of dendritic cells and tumor cells.

Journal of controlled release : official journal of the Controlled Release Society·2026

Pediatric medicines: a brief overview with a focus on drug reformulation and repositioning.

Expert review of clinical pharmacology·2026

Physicochemical and Thermodynamic Basis of Dissolution Enhancement of Biopharmaceutics Classification System Class II Drugs in Deep Eutectic Solvents.

Chemical record (New York, N.Y.)·2026

In vivo fate mapping of a paclitaxel-loaded polymeric micelle and its components.

Acta pharmaceutica Sinica. B·2026

Research trends and hotspots of liposomal bupivacaine: a bibliometric analysis from 2000 to 2025.

Frontiers in medicine·2026

A Novel Insight Into Luspatercept: Therapeutic Implications in Myelodysplastic Syndrome Patients With Elevated Pulmonary Artery Systolic Pressure.

Pulmonary circulation·2026

Two-injection Start Strategy of Aripiprazole Once-monthly Injection: Current Evidence and Clinical Implications.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us